Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Bacterial Infections » Gram-Positive Bacterial Infections » Actinomycetales Infections » Mycobacterium Infections
Description
Infections with bacteria of the genus MYCOBACTERIUM. MeSH
Hierarchy View
Subtype Terms (2)
Mycobacterium Infections, Nontuberculous
14 drugs (10 approved, 4 experimental)
Tuberculosis
247 drugs (145 approved, 102 experimental)
Approved Indicated Drugs (1)
Phase 2 Indicated Drugs (3)
Phase 1 Indicated Drugs (1)
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (56)
Interactive Research and Development
James Cook University Hospital, Middlesbrough, UK
Medical University of South Carolina
National Institute of Allergy and Infectious Diseases (NIAID)
Serum Institute of India Pvt. Ltd.
South Australian Health and Medical Research Institute
University of California, San Diego
University of California, San Francisco
Organization Involved with Phase 2 Indications (31)
Bill and Melinda Gates Foundation
Chatrapati Sahuji Mahraj Medical University
Choithram Hospital and Research Centre
Kidwai Memorial Institute of Oncology, Bangalore
National Center for Research Resources (NCRR)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.